AARP Urges Congress To Lower Prescription Drug Prices
Main Category: Pharmacy / PharmacistAlso Included In: Pharma Industry / Biotech Industry
Article Date: 02 Apr 2009 - 0:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
AARP today testified before the House Energy and Commerce Subcommittee on Commerce, Trade, and Consumer Protection for its hearing on "The Protecting Consumer Access to Generic Drugs Act of 2009" (H.R. 1706). The legislation, sponsored by Reps. Bobby Rush (D-IL) and Henry Waxman (D-CA), will help bring lower cost generic drugs to market sooner by preventing abuses in patent settlements between generic and brand prescription drug companies.
"Lowering prescription drug prices will be a critical part of comprehensive health reform," said AARP Board Member Joanne Handy, who delivered the Association's testimony. "Generic drugs have proven to be one of the safest and most effective ways for consumers to lower their prescription drug costs. Consumers lose when drug makers are able to delay competition by paying off generic manufacturers.
"AARP is proud to endorse 'The Protecting Consumer Access to Generic Drugs Act,' which will put an end to patent settlements that jeopardize the availability of safe, less expensive generic drugs. We look forward to working with Reps. Rush and Waxman and their colleagues to pass their legislation as a part of health reform this year."
AARP's health reform campaign is working to lower prescription drug costs through a variety of changes including ending patent abuse, allowing for the safe and legal importation of lower priced prescription drugs from abroad, closing the Medicare Part D coverage gap, allowing Medicare to negotiate lower prescription drug prices and creating a pathway for the approval of safe generic biologic drugs.
For a complete copy of AARP's testimony to the subcommittee, please contact the Media Relations office at the number above.
AARP is a nonprofit, nonpartisan membership organization that helps people 50+ have independence, choice and control in ways that are beneficial and affordable to them and society as a whole. AARP does not endorse candidates for public office or make contributions to either political campaigns or candidates. We produce AARP The Magazine, the definitive voice for 50+ Americans and the world's largest-circulation magazine with over 34.5 million readers; AARP Bulletin, the go-to news source for AARP's 40 million members and Americans 50+; AARP Segunda Juventud, the only bilingual U.S. publication dedicated exclusively to the 50+ Hispanic community; and our website, AARP.org. AARP Foundation is an affiliated charity that provides security, protection, and empowerment to older persons in need with support from thousands of volunteers, donors, and sponsors. We have staffed offices in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.
Source
AARP
Visit our pharmacy / pharmacist section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/144531.php>
APA
http://www.medicalnewstoday.com/releases/144531.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



